Tres Alchemix
Hakata
About Tres Alchemix
Tres Alchemix is an AI-driven biotechnology company focused on accelerating drug discovery, predicting drug efficacy, and developing novel therapeutic compounds using advanced machine learning and data-driven approaches.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: tresalchemix.com
Social Profiles
Canonical: https://fsome.com/organization/tres-alchemix-40096 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.